![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen to Present At UBS Global Life Sciences Conference
September 17, 2008 11:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Sept. 17, 2008 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for neurological care, announced today that President and CEO Kenneth...
![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen Hosts Research Day
September 03, 2008 08:00 ET
|
Avigen, Inc.
Management and Key Opinion Leaders to Review Product Pipeline and
Development Strategy
Webcast Scheduled for 12:15 p.m. (ET) On Wednesday, September 10,
...
![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen Reports Second Quarter 2008 Financial Results
July 30, 2008 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., July 30, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for neurological care, today reported financial results for its second...
![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen's AV650 Patent Strategy Leads to Expanded Development Agreement
July 23, 2008 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., July 23, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today announced an amendment to the company's...
![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen Reports First Quarter 2008 Financial Results and Discusses AV650 Patent Strategy
April 30, 2008 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., April 30, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today reported financial results for its...
![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen to Present At Cowen & Company Health Care Conference
March 11, 2008 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., March 11, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced today that Chief Business Officer...
![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen to Present At BIO CEO & Investor Conference
February 07, 2008 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 7, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced today that President and Chief...
![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen Reports 2007 Financial Results and Reviews Clinical Progress
February 06, 2008 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 6, 2008 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, today reported financial results for its fourth...
![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen to Present At Upcoming Healthcare Conferences
December 05, 2007 08:00 ET
|
Avigen, Inc.
ALAMEDA, Calif., Dec. 5, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for neurological care, announced today that Avigen will present...
![Avigen, Inc - logo](/news-release/logo/216271/0/216271.gif?lastModified=12%2F09%2F2016%2022%3A56%3A30&size=2)
Avigen to Present At 2007 Credit Suisse Phoenix Health Care Conference
November 08, 2007 18:06 ET
|
Avigen, Inc.
ALAMEDA, Calif., Nov. 8, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for neurological care, announced today that Chief Business Officer...